Thursday, July 11, 2013
Publication and contact
antigen display screening platform
A mammalian platform for
surface antigen display could be used to screen for and discover therapeutic
antibodies. A difficult step for in vitro antibody discovery is the
cloning of candidates discovered via bacterial display systems into mammalian
cell expression systems. In the current platform, human embryonic kidney 293
(HEK293) cells were transfected with a vector that caused them to display a
protein on their surface and secrete it into culture media. The vector also
was used to create HEK293 cell lines that displayed and secreted antibodies,
antibody fragments and antibody fusion proteins. AnaptysBio
Inc. has integrated this system into its SHM-XEL
human antibody generation platform, and next steps include using the platform
to develop therapeutic and diagnostic antibodies.
Published online July 11, 2013
Covered by issued and
pending patents; antibody discovery platform already partnered with multiple
companies and government agencies
Horlick, R.A. et al. J.
Biol. Chem.; published online May 20, 2013;
Contact: Robert A. Horlick, AnaptysBio Inc., San Diego,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]